A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo

被引:465
作者
Rossi, M
Kim, MS
Morgan, DGA
Small, CJ
Edwards, CMB
Sunter, D
Abusnana, S
Goldstone, AP
Russell, SH
Stanley, SA
Smith, DM
Yagaloff, K
Ghatei, MA
Bloom, SR
机构
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Endocrine Unit, Sch Med, London W12 0NN, England
[2] Hoffman La Roche, Nutley, NJ USA
关键词
D O I
10.1210/en.139.10.4428
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Agouti-related protein (Agrp) is present in rat and human hypothalamus and is structurally related to agouti protein. Overexpression of either of these proteins results in obesity. However the effect of exogenous Agrp and its in vivo interaction with alpha-melanocyte stimulating hormone (alpha MSH), the likely endogenous melanocortin 3 and 4 receptor (MC3-R and MC4-R) agonist, have not been demonstrated. We report that 1nmol of Agrp(83-132), a C-terminal fragment of Agrp, when administered intracerebroventricularly (ICV) into rats, increased food intake over a 24-h period (23.0+/-1.4 g saline vs 32.9+/-2.3 g Agrp, p<0.05). The hyperphagia was similar to that seen when 1nmol of the synthetic MC3-R and MC4-R antagonist SHU9119 was given ICV (19.6+/-1.8 g saline vs 32.5+/-1.7 g SHU9119, p<0.001). Both Agrp(83-132) and SHU9119 blocked the reduction in 1-h food intake of ICV alpha MSH at the beginning of the dark phase. This effect occurred independently of whether the antagonists were administered simultaneously, or nine hours prior, to the aMSH. We have also shown Agrp(83-132) is an antagonist at the MC3-R and MC4-R, with similar inhibition of cAMP activation to that previously reported for the full length peptide. In conclusion, Agrp(83-132) administered ICV increases feeding with long lasting effects and is able to inhibit the action of alpha MSH. This interaction may be mediated by the MC3-R and/or MC4-R.
引用
收藏
页码:4428 / 4431
页数:4
相关论文
共 23 条
[1]   Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice [J].
Barrachina, MD ;
Martinez, V ;
Wang, LX ;
Wei, JY ;
Tache, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) :10455-10460
[2]   RECOMBINANT MOUSE OB PROTEIN - EVIDENCE FOR A PERIPHERAL SIGNAL LINKING ADIPOSITY AND CENTRAL NEURAL NETWORKS [J].
CAMPFIELD, LA ;
SMITH, FJ ;
GUISEZ, Y ;
DEVOS, R ;
BURN, P .
SCIENCE, 1995, 269 (5223) :546-549
[3]  
EMESON RB, 1986, J NEUROSCI, V6, P837
[4]   Role of melanocortinergic neurons in feeding and the agouti obesity syndrome [J].
Fan, W ;
Boston, BA ;
Kesterson, RA ;
Hruby, VJ ;
Cone, RD .
NATURE, 1997, 385 (6612) :165-168
[5]   ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors [J].
Fong, TM ;
Mao, C ;
MacNeil, T ;
Kalyani, R ;
Smith, T ;
Weinberg, D ;
Tota, MR ;
VanderPloeg, LHT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 237 (03) :629-631
[6]   Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents [J].
Goldstone, AP ;
Mercer, JG ;
Gunn, I ;
Moar, KM ;
Edwards, CMB ;
Rossi, M ;
Howard, JK ;
Rasheed, S ;
Turton, MD ;
Small, C ;
Heath, MM ;
OShea, D ;
Steere, J ;
Meeran, K ;
Ghatei, MA ;
Hoggard, N ;
Bloom, SR .
FEBS LETTERS, 1997, 415 (02) :134-138
[7]   Overexpression of Agrt leads to obesity in transgenic mice [J].
Graham, M ;
Shutter, JR ;
Sarmiento, U ;
Sarosi, I ;
Stark, KL .
NATURE GENETICS, 1997, 17 (03) :273-274
[8]   Targeted disruption of the melanocortin-4 receptor results in obesity in mice [J].
Huszar, D ;
Lynch, CA ;
FairchildHuntress, V ;
Dunmore, JH ;
Fang, Q ;
Berkemeier, LR ;
Gu, W ;
Kesterson, RA ;
Boston, BA ;
Cone, RD ;
Smith, FJ ;
Campfield, LA ;
Burn, P ;
Lee, F .
CELL, 1997, 88 (01) :131-141
[9]   Melanocortin receptor binding determinants in the agouti protein [J].
Kiefer, LL ;
Veal, JM ;
Mountjoy, KG ;
Wilkinson, WO .
BIOCHEMISTRY, 1998, 37 (04) :991-997
[10]   GALANIN - STIMULATION OF FEEDING INDUCED BY MEDIAL HYPOTHALAMIC INJECTION OF THIS NOVEL PEPTIDE [J].
KYRKOULI, SE ;
STANLEY, BG ;
LEIBOWITZ, SF .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 122 (01) :159-160